OPNT logo

Opiant Pharmaceuticals (OPNT) Cash From Investing

Annual CFI

-$15.01 M
-$14.96 M-29398.43%

December 31, 2021

Summary

Performance

1-Year Change

-29398.43%

3-Year Change

-100%

5-Year Change

-

15-Year Change

-

OPNT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.00
OPNT annual cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$15.01 M
OPNT annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
OPNT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
OPNT next annual earnings announcement has not yet been scheduled

OtherOPNTcash flowmetrics:

Annual CFF

$2.72 M
OPNT annual cash flow from financing activities is $2.72 million

Annual CFO

$1.93 M
OPNT annual cash flow from operations is $1.93 million

Annual FCF

$1.93 M
OPNT annual free cash flow is $1.93 million

Annual CAPEX

-
OPNT annual capital expenditures value is unknown

Quarterly CFI

-$411.10 K
-$2.90 M-116.50%

September 30, 2022

Summary

Performance

3-Month Change

-116.5%

1-Year Change

-1589.49%

3-Year Change

-68.9%

5-Year Change

-

OPNT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.51 M
OPNT quarterly cash flow from investing activities is currently -103.28% below its historical high of $12.51 million

3-Year Low

-$411.10 K
OPNT quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

OtherOPNTcash flowmetrics:

Quarterly CFF

$402.60 K
OPNT quarterly cash flow from financing activities is $402.60 thousand

Quarterly CFO

-$4.74 M
OPNT quarterly cash flow from operations is -$4.74 million

Quarterly FCF

-$5.15 M
OPNT quarterly free cash flow is -$5.15 million

Quarterly CAPEX

-
OPNT quarterly capital expenditures value is unknown

TTM CFI

$14.63 M
-$438.70 K-2.91%

September 30, 2022

Summary

Performance

3-Month Change

-2.91%

1-Year Change

+197.22%

3-Year Change

+4936.57%

5-Year Change

+4936.57%

OPNT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$15.06 M
OPNT TTM cash flow from investing activities is currently -2.91% below its historical high of $15.06 million

3-Year Low

-$15.01 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

OtherOPNTcash flowmetrics:

TTM CFF

$1.19 M
OPNT TTM cash flow from financing activities is $1.19 million

TTM CFO

-$15.47 M
OPNT TTM cash flow from operations is -$15.47 million

TTM FCF

-$15.88 M
OPNT TTM free cash flow is -$15.88 million

TTM CAPEX

-
OPNT TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

OPNT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10000.0%-1589.5%+197.2%
3 y3 years-100.0%-68.9%+4936.6%
5 y5 years--+4936.6%

OPNT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-103.3%at low-2.9%-202.7%
5 y5-year>+9999.0%at low-103.3%+3575.2%-2.9%-203.7%
alltimeall time<-9999.0%at low-103.3%+3575.2%-2.9%-203.7%

Opiant Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2022
-
-$411.10 K(-116.5%)
$14.63 M(-2.9%)
Jun 2022
-
$2.49 M(-80.1%)
$15.06 M(+19.5%)
Mar 2022
-
$12.51 M(>+9900.0%)
$12.61 M(-184.0%)
Dec 2021
-$15.01 M(>+9900.0%)
$30.00 K(+8.7%)
-$15.01 M(-0.2%)
Sep 2021
-
$27.60 K(-24.4%)
-$15.04 M(-0.2%)
Jun 2021
-
$36.50 K(-100.2%)
-$15.07 M(-0.6%)
Mar 2021
-
-$15.11 M(<-9900.0%)
-$15.17 M(>+9900.0%)
Dec 2020
-$50.90 K(-83.2%)
$0.00(0.0%)
-$50.90 K(0.0%)
Sep 2020
-
$0.00(-100.0%)
-$50.90 K(-82.7%)
Jun 2020
-
-$57.50 K(-971.2%)
-$294.30 K(-0.5%)
Mar 2020
-
$6600.00(>+9900.0%)
-$295.80 K(-2.2%)
Dec 2019
-$302.50 K(<-9900.0%)
$0.00(-100.0%)
-$302.40 K(0.0%)
Sep 2019
-
-$243.40 K(+312.5%)
-$302.40 K(+412.5%)
Jun 2019
-
-$59.00 K(<-9900.0%)
-$59.00 K(<-9900.0%)
Mar 2019
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(-100.0%)
Apr 2017
-
$0.00(-100.0%)
-$1000.00(-86.7%)
Jul 2016
-$7500.00
-$1000.00(-84.6%)
-$7500.00(+15.4%)
Apr 2016
-
-$6500.00(<-9900.0%)
-$6500.00(<-9900.0%)
DateAnnualQuarterlyTTM
Apr 2015
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Apr 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2013
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Apr 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2012
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Apr 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2011
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2010
-
$0.00(0.0%)
$0.00(0.0%)
Apr 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2010
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Apr 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jan 2009
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2008
-
$0.00
$0.00
Jul 2008
$0.00
-
-

FAQ

  • What is Opiant Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals annual CFI year-on-year change?
  • What is Opiant Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals quarterly CFI year-on-year change?
  • What is Opiant Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals TTM CFI year-on-year change?

What is Opiant Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of OPNT is -$15.01 M

What is the all time high annual CFI for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high annual cash flow from investing activities is $0.00

What is Opiant Pharmaceuticals annual CFI year-on-year change?

Over the past year, OPNT annual cash flow from investing activities has changed by -$14.96 M (-29398.43%)

What is Opiant Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of OPNT is -$411.10 K

What is the all time high quarterly CFI for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high quarterly cash flow from investing activities is $12.51 M

What is Opiant Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, OPNT quarterly cash flow from investing activities has changed by -$438.70 K (-1589.49%)

What is Opiant Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of OPNT is $14.63 M

What is the all time high TTM CFI for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high TTM cash flow from investing activities is $15.06 M

What is Opiant Pharmaceuticals TTM CFI year-on-year change?

Over the past year, OPNT TTM cash flow from investing activities has changed by +$29.67 M (+197.22%)